| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Guangzhou LBP Medicine Science & Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥15.23 |
| 52 Week High | CN¥27.85 |
| 52 Week Low | CN¥12.83 |
| Beta | 0.41 |
| 11 Month Change | 0.99% |
| 3 Month Change | -11.04% |
| 1 Year Change | -34.64% |
| 33 Year Change | -51.22% |
| 5 Year Change | n/a |
| Change since IPO | -74.82% |
Recent News & Updates
Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Weak Earnings May Only Reveal A Part Of The Whole Picture
Apr 29
Some Confidence Is Lacking In Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHSE:688393) As Shares Slide 25%
Apr 23Recent updates
Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Weak Earnings May Only Reveal A Part Of The Whole Picture
Apr 29Some Confidence Is Lacking In Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHSE:688393) As Shares Slide 25%
Apr 23Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) 31% Price Boost Is Out Of Tune With Earnings
Mar 09Shareholder Returns
| 688393 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 8.0% | -1.7% | -0.8% |
| 1Y | -34.6% | -18.8% | -13.4% |
Return vs Industry: 688393 underperformed the CN Medical Equipment industry which returned -18.8% over the past year.
Return vs Market: 688393 underperformed the CN Market which returned -13.4% over the past year.
Price Volatility
| 688393 volatility | |
|---|---|
| 688393 Average Weekly Movement | 5.1% |
| Medical Equipment Industry Average Movement | 5.3% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in CN Market | 8.8% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 688393 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688393's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 907 | Xiangting Cai | www.gzlbp.com |
Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research, development, and production of pathological diagnosis products in China. The company offers pathological diagnostic reagents and ancillary equipment that consists of liquid-based cytology products, including liquid-based cytology production machines and automatic sample transfer machines; polymerase chain reaction products, such as human papillomavirus gene test kits, sample preservation solutions, and automatic nucleic acid molecular hybridization instruments; fluorescence in situ hybridization products comprising auto-fish instruments, and AML1/ETO, EGFR, BCR/ABL fusion, PML/RARA, and TOP2A gene testing kits; and digital pathology products pathological medical image analysis processing systems, real-time microscopic visual field sharing systems, and bingli scanner.
Guangzhou LBP Medicine Science & Technology Co., Ltd. Fundamentals Summary
| 688393 fundamental statistics | |
|---|---|
| Market cap | CN¥1.43b |
| Earnings (TTM) | CN¥38.32m |
| Revenue (TTM) | CN¥514.40m |
37.2x
P/E Ratio2.8x
P/S RatioIs 688393 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688393 income statement (TTM) | |
|---|---|
| Revenue | CN¥514.40m |
| Cost of Revenue | CN¥169.48m |
| Gross Profit | CN¥344.92m |
| Other Expenses | CN¥306.61m |
| Earnings | CN¥38.32m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.41 |
| Gross Margin | 67.05% |
| Net Profit Margin | 7.45% |
| Debt/Equity Ratio | 0.8% |
How did 688393 perform over the long term?
See historical performance and comparison